EDGAR Filing Documents for 0000921895-09-002598

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0000921895-09-002598

Filing Date

2009-10-20

Accepted

2009-10-20 17:15:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 4 TO THE SCHEDULE 13G	sc13ga407422tar_10202009.htm	SC 13G/A	226160
	Complete submission text file	0000921895-09-002598.txt		228110

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611

Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 200 EAST FIRST STREET SUITE 300 WINSTON-SALEM NC 27101

Business Address 200 EAST FIRST STREET SUITE 300 WINSTON-SALEM NC 27101 3364802100

TARGACEPT INC (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82442 | Film No.: 091128545
SIC: 2834 Pharmaceutical Preparations